MIC+Methyl B12 Injection Recalled for Lack of Processing Controls
Promise Pharmacy is recalling MIC+Methyl B12 injection (57 vials, Lot# 06152021@2) distributed across five states due to lack of processing controls that may affect product quality and safety.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The source indicates this is an FDA Class II recall. Class II recalls, particularly for sterile injectable drugs with manufacturing control defects, pose significant risk of serious adverse health consequences including potential infection or loss of therapeutic efficacy, meeting the Severe criterion.
Plain-English summary
Promise Pharmacy, LLC is recalling MIC+Methyl B12 injection, a prescription sterile injectable product containing Methionine, Inositol, Choline, and Methylcobalamin (25 mg/50 mg/50 mg/1 mg/mL). The recall affects 57 vials with Lot# 06152021@2 (expiration date 09/13/2021) distributed to Arizona, Colorado, Florida, Illinois, and New Jersey.
The recall is due to lack of processing controls. The manufacturer failed to implement adequate controls during production, which may compromise the product's sterility, potency, or safety.
Healthcare providers and patients who have this product should stop using it immediately and contact Promise Pharmacy at 1-888-3PROMIS for instructions on return or disposal. Patients should consult their healthcare provider regarding alternative treatments.
The recalled product
- Product
- MIC+Methyl B12 injection Methionine Inositol Choline+Methylcobalamin 25 mg/50 mg/50 mg/1 mg/mL, 10 mL vial sterile, Rx only, Promise Pharmacy 31818 US Hwy 19N Palm Harbor FL 34684 1-888-3PROMIS
- Manufacturer
- Promise Pharmacy, LLC
- Category
- Drug — Injectable / Compounded
- Hazard
- manufacturing-defect
- sterility-risk
- lack-of-controls
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot# 06152021@2
- Exp 09/13/2021
Distribution
Distributed in 5 states:
- AZ
- CO
- FL
- IL
- NJ
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27